Powered by OpenAIRE graph
Found an issue? Give us feedback

IDIVAL

FUNDACION INSTITUTO DE INVESTIGACION MARQUES DE VALDECILLA
Country: Spain
6 Projects, page 1 of 2
  • Funder: European Commission Project Code: 2018-1-FR01-KA202-047959
    Funder Contribution: 220,150 EUR

    "In terms of support and integration of learners living with psychological disturbances, several observations are shared on the field:Vocational education and training (VET) professionals lack the knowledge, tools and experience to support and monitor these groups;More and more learners in VET organisations are affected by psychological disorders;These learners are more likely to drop out and abandon their training/integration pathway due to lack of adequate supportProfessionals in the sector declare themselves helpless in the face of this situation, not having references or resources adapted to the reality of VET in terms of support for these particular groups.In order to address this issue, seven partner organisations from six European countries came together to cooperate at European level on the issue of support for learners with psychological disorders. Actors from the fields of education, vocational training and socio-professional integration on the one hand, and experts in psychology/mental health and in the support of people suffering from mental health disorders on the other, have come together to develop common solutions thanks to a global approach to the challenge which brings them together.Thus, the Psych Up project aims at improving the support of learners living with psychological disorders during their training/education pathway, by paving the way for the emergence and professionalisation of ""psychological disorders referents"" in VET organisations in Europe. This objective will lead to two results:The adaptation of the support and training pathway for learners with psychological disordersThe development of a community of practice at European level to exchange and enhance field practices for the support of learnersThe project intends to reach its objectives by working on the clarification of the role, missions and competences of the ""referent in psychological disorders in VET"" (or ""Psych Up Referent"") thanks to its 3 productions A common function profile, highlighting the specific tasks, roles and competences of the Psych Up Referent, as well as six versions adapted to the national contexts of the partnersA common training framework, presenting the ideal training pathway for the Psych Up Facilitator: learning objectives, training contents, ...; as well as six versions adapted to the national contexts of the partnersA collection of resources for the Psych Up Referent, including more than 60 resources useful to professionals in the field for the discovery, management and support of psychological disorders in training Thanks to these common references, throughout Europe, VET professionals will be able to adapt and improve the support and supervision of learners living with psychological disorders in training, in order to guarantee them a better socio-professional integration"

    more_vert
  • Funder: European Commission Project Code: 101095679
    Overall Budget: 6,721,930 EURFunder Contribution: 6,721,930 EUR

    Non-alcoholic fatty liver disease (NAFLD) is a multifactorial chronic inflammatory disease that is prevalent in 1 of 4 individuals with a significant personal, socioeconomic and healthcare burden, especially at the later, more severe inflammatory stage of disease - non-alcoholic steatohepatitis (NASH). Despite the severe negative impact of the disease on society, NAFLD remains difficult to diagnose and treat. Additionally, the molecular mechanisms underlying the transition from health to fatty liver to NASH remain poorly understood due to the lack of models that faithfully reflect the complexity of human disease. Hence, Halt-RONIN aims to uncover the early triggers of disease initiation and complex mechanistic drivers of disease progression by implementing a systems biology approach with integrative disease modelling resulting in opportunities for the improvement of the existing detection methods, providing a blueprint to inform personalized intervention strategies and drug discovery for NAFLD. To achieve this goal, Halt-RONIN will combine experimental data from advanced in vitro and in vivo models with multimodal data from extensive human NAFLD cohorts and biobanks and use in silico machine learning approaches, to discover new biomarkers and molecular targets specific to each stage of the health-to-disease transition. By validating preclinical experimental findings with real-world data, RONIN will allow for the discovery of novel biomarkers and molecular targets that are specific to the individual patient’s pathology. Consequently, healthcare professionals will gain the tools and knowledge required to diagnose and establish guidelines for the prevention and treatment of inflammation-driven health to disease. As such, in the long-term RONIN will decrease the number of NAFL patients who progress into NASH and provide disease-modifying strategies to improve patient outcomes.

    more_vert
  • Funder: European Commission Project Code: 101073025
    Funder Contribution: 2,734,400 EUR

    Metastatic melanoma is a hard-to-treat disease and it remains as one of the most worrisome cancer. There is an urgent need to improve the current therapies (chemotherapy, radiotherapy) that have a limited efficacy. A single therapy is not efficient to tackle metastatic melanoma and a combination of therapies is thus emerging as a necessity to efficiently eradicate all cancer cells. Recently, the development of immunotherapies has shown promises, in particular chimeric antigen receptor (CAR)-T cells. Nevertheless, the physical barriers represented by cellular and non-cellular components of the tumor microenvironment combined to the abnormal tumor vasculature and high interstitial fluid pressure, hamper an efficient tumour infiltration of CAR-T cells. In this context, thanks to a network of 18 partners (including 10 non-academic partners), MELOMANES aims to train doctoral researchers for the development of a combined therapy exploiting the properties of magnetic nanoparticles to induce damage on the tumor microenvironment by magnetic and optic hyperthermia in order to facilitate the infiltration of CAR-T cells. This therapeutic approach combining hyperthermia and immunotherapy is versatile, as it could be also applied to other types of solid tumors. Research and transferable training of the doctoral researchers will be performed in a highly interdisciplinary, intersectoral, and international environment. In addition to acquiring skills related to the research project, they will be trained also in open science, communication and dissemination, responsible research and innovation, circular economy, ethics, data management, entrepreneurship, marketing, intellectual property, and gender dimension in research. Their competences will be validated through certification and qualification examination, allowing a new generation of highly skilled doctoral researchers to emerge with a high-level training in particular in the multidisciplinary field of nanomedicine.

    more_vert
  • Funder: European Commission Project Code: 101017424
    Overall Budget: 5,737,060 EURFunder Contribution: 5,737,060 EUR

    Coronary artery disease (CAD) remains the leading cause of disease burden globally. CAD develops slowly, usually over decades, and depends on multiple (often modifiable) risk factors and their interactions. Self-management and patient activation are of rising importance as current restrictions in healthcare budgets impose great difficulties to enable the provision of qualitative secondary prevention to all cardiac patients in an era facing a huge cardiovascular disease epidemic. The main hypothesis in the patient-centered TIMELY pathway, is that a modular, collaborative eHealth platform, supported by Artificial Intelligence (AI) for the continuous and in-time prediction of cardiac risks and complications and the induction of targeted behavioural change interventions, can be effective and cost-efficient for the secondary prevention of CAD by limiting the physiological and psychological effects of the disease and improving risk factor and symptom management. Improvements in patients’ self-care and empowerment and clinicians’ efficiency are also expected. Along the continuum of the disease, prediction of the individual risk for disease progression, including physical impairment and severe events, is mandatory for timely intervention. TIMELY is a platform that provides AI-powered apps and dashboards and decision support tools assisting patients and clinicians to personalize healthcare based on risk evaluation, outcome prediction and tailored interventions. The platform will be developed based on a functional platform for Interoperability with electronic health records and security mechanisms, to ensure information completeness and continuity and to simplify data sharing. AI in TIMELY, built with big retrospective datasets of >23.000 CAD patients, will constantly monitor and evaluate risks and will indicate any deviation from defined therapy goals or unfavorable changes as well as propose proper interventions.

    more_vert
  • Funder: European Commission Project Code: 101095654
    Overall Budget: 305,248,992 EURFunder Contribution: 91,574,600 EUR

    Health and care systems in Europe are facing core common challenges, which require harmonised and coordinated solutions. The European Partnership on Transforming Health and Care Systems (THCS) represents a unique strategic opportunity to bring together stakeholders, create synergies, coordinate Research and Innovation actions, facilitate the digitization of health and care services and support the transformation of health and care systems with innovative solutions driven by knowledge and evidence. The general objective of THCS is to contribute to the transition towards more sustainable, efficient, resilient, inclusive, innovative and high-quality people-centred health and care systems equally accessible to all people. For this purpose, THCS aims not only to create new knowledge and scientific evidence but to co-design new solutions and support their transfer and scale-up across countries and regions while also fostering capacity building. The approach for a successful and smooth implementation of THCS will focus on three main work streams: 1) Filling the knowledge gaps with research actions aiming at providing the necessary evidence, 2) Implementation and transfer aiming at supporting actions focusing on the testing of existing solutions and adaptability in different national and regional contexts, and 3) Boosting health and care systems through dedicated activities (capacity building and trainings, study visits, technical assistance, twinning, networking) involving different health and care stakeholders. To address these three work streams, THCS is built around four pillars that group different types of activities addressing different types of stakeholders of the health and care system. The activities are organised in ten Work Packages working closely together to achieve the objectives of the Partnership and clustered in the four Pillars.

    more_vert
  • chevron_left
  • 1
  • 2
  • chevron_right

Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.

Content report
No reports available
Funder report
No option selected
arrow_drop_down

Do you wish to download a CSV file? Note that this process may take a while.

There was an error in csv downloading. Please try again later.